Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AKT-IN-23

AKT-IN-23 is an AKT inhibitor. AKT-IN-23 can be used in cancer research[1].

Product Specifications

CAS Number

1226801-23-5

UNSPSC

12352005

Target

Akt

Type

Reference compound

Related Pathways

PI3K/Akt/mTOR

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/akt-in-23.html

Purity

98.96

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O=C1NC2=NC=NC(N3CCC(CC3)C4=NC(C5=CC(C(F)(F)F)=C(F)C=C5)=CN4CCN(C)C)=C2C1

Molecular Formula

C25H27F4N7O

Molecular Weight

517.52

References & Citations

[1]Timothy Alan Shepherd, et al. Akt and p70 s6 kinase inhibitors.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD3e (RIV9), CF680R conjugate, 0.1mg/mL
BNC810322-100 1x 100 µL

CD3e (RIV9), CF680R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD104 (UM-A9), CF488A conjugate, 0.1mg/mL
BNC880449-500 1x 500 µL

CD104 (UM-A9), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD45RO (UCHL-1), CF568 conjugate, 0.1mg/mL
BNC680003-500 1x 500 µL

CD45RO (UCHL-1), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Mucin 5AC (MUC5AC) (45M1), CF647 conjugate, 0.1mg/mL
BNC470031-500 1x 500 µL

Mucin 5AC (MUC5AC) (45M1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD8 (RIV11), CF405S conjugate, 0.1mg/mL
BNC040333-500 1x 500 µL

CD8 (RIV11), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD147 (BSG/963), CF647 conjugate, 0.1mg/mL
BNC470963-100 1x 100 µL

CD147 (BSG/963), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details